Immucell reports preliminary unaudited Q1 revenue $6.4M vs. $5.5M last year

“Our investments to increase production capacity to over $30M per year were challenging and did take longer than we had planned. We are now evaluating incremental liquid processing and freeze-drying investments to increase capacity by an additional 33% to approximately $40M or more to capitalize on potential demand growth in the North American dairy and beef markets,” commented Michael Brigham, CEO. “Although buffer stock replenishment and backlog depletion may result in one-time lifts in volume, our teams remain focused on the sustainable, long-term growth of the First Defense product line.”